Publication | Closed Access

Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.

Hematological MalignancySurgical OncologyTransplantationMarrow TransplantationPediatric HematologyMedicineRecurrent Rhabdomyosarcoma BenefitHematologyHematopoietic RescueHigh-dose TherapySurgeryOncologyCell Transplantation